These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37291193)

  • 21. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
    Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
    Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.
    Pauzi FA; Azizan EA
    Front Endocrinol (Lausanne); 2021; 12():631848. PubMed ID: 33763031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism.
    Sun N; Meyer LS; Feuchtinger A; Kunzke T; Knösel T; Reincke M; Walch A; Williams TA
    Hypertension; 2020 Mar; 75(3):634-644. PubMed ID: 31957522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
    Zhou J; Azizan EAB; Cabrera CP; Fernandes-Rosa FL; Boulkroun S; Argentesi G; Cottrell E; Amar L; Wu X; O'Toole S; Goodchild E; Marker A; Senanayake R; Garg S; Åkerström T; Backman S; Jordan S; Polubothu S; Berney DM; Gluck A; Lines KE; Thakker RV; Tuthill A; Joyce C; Kaski JP; Karet Frankl FE; Metherell LA; Teo AED; Gurnell M; Parvanta L; Drake WM; Wozniak E; Klinzing D; Kuan JL; Tiang Z; Gomez Sanchez CE; Hellman P; Foo RSY; Mein CA; Kinsler VA; Björklund P; Storr HL; Zennaro MC; Brown MJ
    Nat Genet; 2021 Sep; 53(9):1360-1372. PubMed ID: 34385710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
    De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
    J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
    Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
    Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
    Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
    Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
    Harashima S; Yamazaki Y; Motomura N; Ono Y; Omata K; Tezuka Y; Morimoto R; Nakamura Y; Satoh F; Suzuki H; Kwon GE; Choi MH; Sasano H
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106116. PubMed ID: 35533918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas.
    Nanba K; Rainey WE
    Eur J Endocrinol; 2021 May; 185(1):R1-R11. PubMed ID: 33900205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism.
    Omata K; Yamazaki Y; Nakamura Y; Anand SK; Barletta JA; Sasano H; Rainey WE; Tomlins SA; Vaidya A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1792-1796. PubMed ID: 28368480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
    Yamazaki Y; Nakamura Y; Omata K; Ise K; Tezuka Y; Ono Y; Morimoto R; Nozawa Y; Gomez-Sanchez CE; Tomlins SA; Rainey WE; Ito S; Satoh F; Sasano H
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1182-1192. PubMed ID: 28388725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
    Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
    World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
    Recarti C; Seccia TM; Caroccia B; Gonzales-Campos A; Ceolotto G; Lenzini L; Petrelli L; Belloni AS; Rainey WE; Nussberger J; Rossi GP
    J Hypertens; 2015 May; 33(5):1014-22. PubMed ID: 25668351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
    Chen YJ; Peng KY; Chueh JS; Liao HW; Hsieh TY; Wu VC; Wang SM
    Front Endocrinol (Lausanne); 2022; 13():816754. PubMed ID: 35399924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.